Alfa Wassermann Diagnostic Technologies and Hitachi to Partner for Clinical Chemistry Analyzer Sales in USA
West Caldwell, NJ, and Tokyo, Japan, May 29, 2007 –– Alfa Wassermann Diagnostic Technologies, LLC and Hitachi, Ltd. (NYSE: HIT / TSE: 6501) today announced that they have entered into a distribution and maintenance / service agreement on partnership to sell and market Hitachi’s clinical chemistry systems for the Physician Office Laboratory (POL) market in the United States.
The small practice segment of the POL laboratory market is the largest and fastest growing segment in the United States. Most small practices do not have in-house clinical chemistry test capability; samples are typically sent out to reference laboratories. The need exists for immediate test results at the point of care.
To address this need, Alfa Wassermann and Hitachi have entered into a distribution and service agreement for Hitachi’s Clinical Analyzer S40 in the United States. In making the announcement, both parties commented on the partnership:
Douglas Danne, President of Alfa Wassermann Diagnostic Technologies, LLC, said, “Through this agreement, we are partnering with an organization that will assist us in our goal to provide exciting new technology and innovative solutions for practicing physicians. Our strategy is focused on expanding and diversifying Alfa Wassermann’s current portfolio of clinical chemistry systems and acquiring technologies that can be applied to strengthen and add value to our already broad portfolio.”
Hiroshi Mitsumaki, President and CEO of Personal Healthcare Venture Company, Hitachi, Ltd., explains that the partnership is a natural one. “We are excited to be working with Alfa Wassermann to provide solutions for the POL marketplace in the United States. We entered into this strategic partnership with Alfa Wassermann because they are the leader in the POL market. We are looking forward to a long and successful partnership. We also believe that Hitachi’s desktop size clinical chemistry system will certainly satisfy the needs at physician’s offices in the United States.”
The initial product offering will be the revolutionary Hitachi S40 desktop clinical chemistry analyzer that combines the accuracy and flexibility of large scale systems with the ease of use and convenience required in the POL setting. Alfa Wassermann and Hitachi plan to unveil Hitachi Clinical Analyzer S40 to the United States market at the annual American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in San Diego, CA on July 17, 2007.
The focus will be on the ability to offer a “Total Solution” to end-users. Alfa Wassermann and Hitachi will begin an aggressive campaign to release innovative solutions that meet these needs. Further product announcements will be forthcoming.
Alfa Wassermann Diagnostic Technologies, LLC is a leading provider of medical diagnostic instrumentation and reagents to the medical community. Its primary focus is the POL with a growing presence in hospital laboratories and veterinary clinics.
Alfa Wassermann Diagnostics Technologies, LLC
4 Henderson Drive
West Caldwell, NJ 07006 United States
Alfa Wassermann's diagnostic technology products include the ACE Alera®, ACE®, and VetACE™ systems that are sold around the world to physician, veterinary, and research laboratories, including many of the leading pharmaceutical companies, academic institutions, and animal conservancies.
Hitachi, Ltd., (NYSE: HIT / TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 384,000 employees worldwide. Fiscal 2006 (ended March 31, 2007) consolidated revenues totaled 10,247 billion yen ($86.8 billion). The company offers a wide range of systems, products and services in market sectors including information systems, electronic devices, power and industrial systems, consumer products, materials and financial services. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.
Diagnostic Technologies, LLC
+1-800-220-4488 ext 3456
Hitachi America, Ltd.